Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review

Introduction

About this Report

This new 389-page report from VPG Market Research presents detailed analysis of the Enteric Disease market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan.  Current scientific views on epidemiology and etiology are presented for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia.  The report provides test volume and sales forecasts by country and market segment, including:

     - Hospitals
     - Commercial/Private Labs
     - Physician Offices
     - Public Health Labs

In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of enteric disease diagnostic products, by test and country.  Also, the report:

     -  Examines market applications of Molecular Diagnostics,  
        Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;

     -  Reviews features and operating characteristics of major analyzers used
        for enteric disease testing;

     -  Profiles key suppliers and potential market entrants developing innovative
        technologies and products; and

     -  Analyzes emerging opportunities, alternative market penetration strategies,
         market entry barriers/risks, and strategic planning issues.

Methodology

The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the U.S., five major European countries and Japan.

In addition to primary sources of information, a comprehensive review of
the most recent technical and business publications, manufacturer product
and financial literature, as well as VPGMarketResearch’s proprietary data files was conducted.

Contains 389 pages and 97 tables

Table of Contents
for Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review

• Table of Content - click REQUEST A SAMPLE BUTTON

List Of Tables
in Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review

Competitive Assessments

- Abbott

- Affymetrix

- Beckman Coulter/Danaher

- Becton Dickinson

- bioMerieux

- Bio-Rad

- Cepheid

- Diamedix

- DiaSorin

- Eiken Chemical

- Elitech Group

- Enzo Biochem

- Fujirebio

- Grifols

- Hologic/Gen-Probe

- ID Biomedical/GSK

- Kreatech/Leica

- Lonza

- Ortho-Clinical Diagnostics

- Qiagen

- Roche

- Scienion

- Sequenom

- SeraCare

- Siemens

- Takara Bio

- Thermo Fisher/Life Technology

- Wallac/PE

- Wako

Additional Details

Publisher

Venture Planning Group (VPG)

Publisher Information

Reference

59061 | VPID19152

Number of Pages

389

Report Format

PDF

Related Reports